Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2009-01-22 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SOMMIERES (30250), Gard
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DU PONT ROMAIN : revenue, balance sheet and financial ratios
SELARL PHARMACIE DU PONT ROMAIN is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SOMMIERES (30250),
this company of category PME
shows in 2024 a net income positive of 67 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DU PONT ROMAIN (SIREN 510174410)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
67 012 €
66 807 €
102 159 €
116 553 €
82 479 €
74 334 €
65 773 €
44 659 €
54 271 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DU PONT ROMAIN generates positive net income of 67 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 54 k€ -> 67 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
67 012 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 55%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
54.832%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.746%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DU PONT ROMAIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
266.695
230.213
183.133
146.296
165.178
131.161
100.912
76.872
54.832
Financial autonomy
24.97
27.551
32.392
36.914
35.173
39.921
46.594
51.946
59.746
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
54.832024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-8 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DU PONT ... (54.83) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.75%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+13 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DU PONT ... (59.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 216.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
216.451
Liquidity indicators evolution SELARL PHARMACIE DU PONT ROMAIN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
141.674
137.905
121.382
112.342
370.214
374.64
388.073
273.951
216.451
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
216.452024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-14 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DU PONT ... (216.45) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELARL PHARMACIE DU PONT ROMAIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DU PONT ROMAIN is estimated at
935 537 €
(range 651 493€ - 1 399 616€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
651k€935k€1399k€
935 537 €Range: 651 493€ - 1 399 616€
NAF 5 année 2024
Valuation method used
Net Income Multiple
67 012 €
×
14.0x
=935 537 €
Range: 651 493€ - 1 399 617€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DU PONT ROMAIN with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DU PONT ROMAIN
What is the revenue of SELARL PHARMACIE DU PONT ROMAIN ?
The revenue of SELARL PHARMACIE DU PONT ROMAIN is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DU PONT ROMAIN profitable?
Yes, SELARL PHARMACIE DU PONT ROMAIN generated a net profit of 67 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DU PONT ROMAIN ?
The headquarters of SELARL PHARMACIE DU PONT ROMAIN is located in SOMMIERES (30250), in the department Gard.
Where to find the tax return of SELARL PHARMACIE DU PONT ROMAIN ?
The tax return of SELARL PHARMACIE DU PONT ROMAIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DU PONT ROMAIN operate?
SELARL PHARMACIE DU PONT ROMAIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart